GlycoScoreDx is a startup based in the United Kingdom, most recent round Seed, 1 tracked investor.
Based in the United Kingdom, GlycoScoreDx is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
GlycoScoreDx focuses on prostate cancer diagnosis through its blood test. The GlycoScore Prostate Cancer Test utilizes a combination of glycan biomarkers to detect aggressive prostate cancer and differentiate it from benign conditions, thereby reducing the need for biopsies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.